Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Czibere Akos
Over the trailing 90 days, Czibere Akos (Other at Aktis Oncology, Inc.) traded $1.6M of stock (net selling $1.1M) in AKTS, per 5 SEC Form 4 transactions.
- Role
- Other
- Companies
- AKTS
- Window
- Trailing 90 days · 5 transactions · CIK 2049427
- Net activity
- −$1.1M ($248K bought · $1.4M sold)
By Company (Trailing 90 Days)
| Symbol | Company | Txns | Bought | Sold | Net |
|---|---|---|---|---|---|
| AKTS | Aktis Oncology, Inc. | 5 | $248K | $1.4M | −$1.1M |
Transactions (5)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-07-08 | AKTS | Sell | 50.0K | $0 | Exercise or conversion of derivative security |
| 2026-07-08 | AKTS | Buy | 50.0K | $248K | Exercise or conversion of derivative security |
| 2026-07-08 | AKTS | Sell | 14.8K | $401K | Open market or private sale |
| 2026-07-08 | AKTS | Sell | 30.8K | $862K | Open market or private sale |
| 2026-07-08 | AKTS | Sell | 4.4K | $125K | Open market or private sale |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Czibere's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.